203 related articles for article (PubMed ID: 12618026)
1. Cytoplasmic delivery and nuclear targeting of synthetic macromolecules.
Jensen KD; Nori A; Tijerina M; Kopecková P; Kopecek J
J Control Release; 2003 Feb; 87(1-3):89-105. PubMed ID: 12618026
[TBL] [Abstract][Full Text] [Related]
2. Antisense oligonucleotides delivered to the lysosome escape and actively inhibit the hepatitis B virus.
Jensen KD; Kopecková P; Kopecek J
Bioconjug Chem; 2002; 13(5):975-84. PubMed ID: 12236779
[TBL] [Abstract][Full Text] [Related]
3. Targetable HPMA copolymer-adriamycin conjugates. Recognition, internalization, and subcellular fate.
Omelyanenko V; Kopecková P; Gentry C; Kopecek J
J Control Release; 1998 Apr; 53(1-3):25-37. PubMed ID: 9741911
[TBL] [Abstract][Full Text] [Related]
4. Tat-conjugated synthetic macromolecules facilitate cytoplasmic drug delivery to human ovarian carcinoma cells.
Nori A; Jensen KD; Tijerina M; Kopecková P; Kopecek J
Bioconjug Chem; 2003; 14(1):44-50. PubMed ID: 12526691
[TBL] [Abstract][Full Text] [Related]
5. Correlation of subcellular compartmentalization of HPMA copolymer-Mce6 conjugates with chemotherapeutic activity in human ovarian carcinoma cells.
Tijerina M; Kopecková P; Kopecek J
Pharm Res; 2003 May; 20(5):728-37. PubMed ID: 12751627
[TBL] [Abstract][Full Text] [Related]
6. The cytoplasmic escape and nuclear accumulation of endocytosed and microinjected HPMA copolymers and a basic kinetic study in Hep G2 cells.
Jensen KD; Kopecková P; Bridge JH; Kopecek J
AAPS PharmSci; 2001; 3(4):E32. PubMed ID: 12049495
[TBL] [Abstract][Full Text] [Related]
7. Mechanisms of cytotoxicity in human ovarian carcinoma cells exposed to free Mce6 or HPMA copolymer-Mce6 conjugates.
Tijerina M; Kopecková P; Kopecek J
Photochem Photobiol; 2003 Jun; 77(6):645-52. PubMed ID: 12870851
[TBL] [Abstract][Full Text] [Related]
8. Water-soluble polymers for targeted drug delivery to human squamous carcinoma of head and neck.
Nan A; Ghandehari H; Hebert C; Siavash H; Nikitakis N; Reynolds M; Sauk JJ
J Drug Target; 2005 Apr; 13(3):189-97. PubMed ID: 16036307
[TBL] [Abstract][Full Text] [Related]
9. The effects of subcellular localization of N-(2-hydroxypropyl)methacrylamide copolymer-Mce(6) conjugates in a human ovarian carcinoma.
Tijerina M; Kopecková P; Kopecek J
J Control Release; 2001 Jul; 74(1-3):269-73. PubMed ID: 11489506
[TBL] [Abstract][Full Text] [Related]
10. Molecular imaging of HPMA copolymers: visualizing drug delivery in cell, mouse and man.
Lu ZR
Adv Drug Deliv Rev; 2010 Feb; 62(2):246-57. PubMed ID: 20060431
[TBL] [Abstract][Full Text] [Related]
11. Doxorubicin-loaded, charge reversible, folate modified HPMA copolymer conjugates for active cancer cell targeting.
Li L; Yang Q; Zhou Z; Zhong J; Huang Y
Biomaterials; 2014 Jun; 35(19):5171-87. PubMed ID: 24702960
[TBL] [Abstract][Full Text] [Related]
12. Subcellular trafficking of HPMA copolymer-Tat conjugates in human ovarian carcinoma cells.
Nori A; Jensen KD; Tijerina M; Kopecková P; Kopecek J
J Control Release; 2003 Aug; 91(1-2):53-9. PubMed ID: 12932637
[TBL] [Abstract][Full Text] [Related]
13. Direct Cytoplasmic Delivery and Nuclear Targeting Delivery of HPMA-MT Conjugates in a Microtubules Dependent Fashion.
Zhong J; Zhu X; Luo K; Li L; Tang M; Liu Y; Zhou Z; Huang Y
Mol Pharm; 2016 Sep; 13(9):3069-79. PubMed ID: 27417390
[TBL] [Abstract][Full Text] [Related]
14. Design of a multivalent galactoside ligand for selective targeting of HPMA copolymer-doxorubicin conjugates to human colon cancer cells.
David A; Kopecková P; Minko T; Rubinstein A; Kopecek J
Eur J Cancer; 2004 Jan; 40(1):148-57. PubMed ID: 14687799
[TBL] [Abstract][Full Text] [Related]
15. HPMA copolymer-anticancer drug-OV-TL16 antibody conjugates. II. Processing in epithelial ovarian carcinoma cells in vitro.
Omelyanenko V; Gentry C; Kopecková P; Kopecek J
Int J Cancer; 1998 Feb; 75(4):600-8. PubMed ID: 9466663
[TBL] [Abstract][Full Text] [Related]
16. Targeting tumor angiogenesis: comparison of peptide and polymer-peptide conjugates.
Line BR; Mitra A; Nan A; Ghandehari H
J Nucl Med; 2005 Sep; 46(9):1552-60. PubMed ID: 16157540
[TBL] [Abstract][Full Text] [Related]
17. Tumor targeting by pH-sensitive, biodegradable, cross-linked N-(2-hydroxypropyl) methacrylamide copolymer micelles.
Zhou Z; Li L; Yang Y; Xu X; Huang Y
Biomaterials; 2014 Aug; 35(24):6622-35. PubMed ID: 24814427
[TBL] [Abstract][Full Text] [Related]
18. Enhanced nuclear delivery of H1-S6A, F8A peptide by NrTP6-modified polymeric platform.
Xie D; Wang F; Xiang Y; Huang Y
Int J Pharm; 2020 Apr; 580():119224. PubMed ID: 32173501
[TBL] [Abstract][Full Text] [Related]
19. Synthesis and in vitro anti-tumor activity of novel HPMA copolymer-drug conjugates with potential cell surface targeting property for carcinoma cells.
Xiang Q; Yang Y; Zhou Z; Zhou D; Jin Y; Zhang Z; Huang Y
Eur J Pharm Biopharm; 2012 Feb; 80(2):379-86. PubMed ID: 22101181
[TBL] [Abstract][Full Text] [Related]
20. Designing polymer conjugates as lysosomotropic nanomedicines.
Duncan R
Biochem Soc Trans; 2007 Feb; 35(Pt 1):56-60. PubMed ID: 17233601
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
